The active Zot domain (aa 288–293) increases ZO‐1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO‐1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation

Vibrio cholerae‐derived zonula occludins toxin (Zot) is a multifunctional protein that reversibly disassembles intestinal tight junctions (tjs). Zot structure‐function analysis has mapped this activity to aa 288–293, named AT1002. AT1002 reduced transepithelial electrical resistance across rat small intestine, ex vivo, as did Zot and its processed mature form, ΔG. AT1002 increased in vivo permeability to sugar tracers, whereas scrambled control peptides did not. Binding and barrier assays in proteinase activated receptor (PAR)2‐expressing and PAR2‐null cells established AT1002 activity to be PAR2 dependent. Coincident with the increased intestinal permeability, confocal microscopy of AT1002‐exposed rat intestinal IEC6 cells revealed displacement of ZO‐1 and occludin from intercellular boundaries. In coimmunoprecipitation assays, AT1002 decreased ZO‐1‐occludin and ZO‐1‐claudin 1 interactions coincident with PKCα‐dependent ZO‐1 serine/threonine phosphorylation. Further, AT1002 increased serine phosphorylation of myosin 1C and, at the same time, transiently diminished its association with ZO‐1. The COOH‐terminal domain of ZO‐1 was required for its association with myosin 1C. These data indicate that the NH2‐terminal portion of active Zot contains a PAR2‐activating motif, FCIGRL, that increases PKCα‐dependent ZO‐1 and myosin 1C serine/threonine phosphorylation. These modifications provoke selective disengagement of ZO‐1 from its binding partners, occludin, claudin 1, and myosin 1C, coincident with opening of tjs.—Goldblum, S. E., Rai, U., Tripathi, A., Thakar, M., De Leo, L., Di Toro, N., Not, T., Ramachandran, R., Puche, A. C., Hollenberg, M. D., Fasano, A. The active Zot domain (aa 288–293) increases ZO‐1 and myosin 1C serine/ threonine phosphorylation, alters interaction between ZO‐1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J. 25, 144–158 (2011). www.fasebj.org

[1]  A. Passaniti,et al.  Epidermal Growth Factor-like Repeats of Thrombospondins Activate Phospholipase Cγ and Increase Epithelial Cell Migration through Indirect Epidermal Growth Factor Receptor Activation* , 2009, Journal of Biological Chemistry.

[2]  Liping Su,et al.  Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. , 2009, Gastroenterology.

[3]  A. Tripathi,et al.  Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. , 2009, International journal of pharmaceutics.

[4]  Masahiro Sokabe,et al.  Mechanical forces facilitate actin polymerization at focal adhesions in a zyxin-dependent manner , 2008, Journal of Cell Science.

[5]  L. Buéno,et al.  Protease‐activated receptor 2 and gut permeability: a review , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[6]  Takashi Kojima,et al.  Transmembrane proteins of tight junctions. , 2008, Biochimica et biophysica acta.

[7]  C. V. Van Itallie,et al.  The density of small tight junction pores varies among cell types and is increased by expression of claudin-2 , 2008, Journal of Cell Science.

[8]  James M. Anderson,et al.  The unique-5 and -6 motifs of ZO-1 regulate tight junction strand localization and scaffolding properties. , 2007, Molecular biology of the cell.

[9]  S. Vanner,et al.  Protease‐activated receptor 2 sensitizes TRPV1 by protein kinase Cɛ‐ and A‐dependent mechanisms in rats and mice , 2006, The Journal of physiology.

[10]  James M. Anderson,et al.  Dimerization of the Scaffolding Protein ZO-1 through the Second PDZ Domain* , 2006, Journal of Biological Chemistry.

[11]  T. Matsui,et al.  ZO-1 and ZO-2 Independently Determine Where Claudins Are Polymerized in Tight-Junction Strand Formation , 2006, Cell.

[12]  W. Lencer,et al.  Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure , 2006, Journal of Cell Science.

[13]  M. Kondo,et al.  Ion transport regulated by protease‐activated receptor 2 in human airway Calu‐3 epithelia , 2005, British journal of pharmacology.

[14]  R. Marzari,et al.  Dual sugar gut-permeability testing on blood drop in animal models. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[15]  M. Hollenberg.  Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more. , 2003, Life sciences.

[16]  M. Rędowicz,et al.  Effect of Rho family GTP-binding proteins on Amoeba proteus , 2003, Protoplasma.

[17]  G. Coppa,et al.  Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. , 2002, Gastroenterology.

[18]  James M. Anderson,et al.  Isolation and functional characterization of the actin‐binding region in the tight junction protein ZO‐1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  T. Meyer,et al.  Zonula Occludens-1 Is a Scaffolding Protein for Signaling Molecules , 2002, The Journal of Biological Chemistry.

[20]  A. Fasano,et al.  Zonula Occludens Toxin Structure-Function Analysis , 2001, The Journal of Biological Chemistry.

[21]  C. V. Van Itallie,et al.  Occludin Localization at the Tight Junction Requires the Second Extracellular Loop , 2000, The Journal of Membrane Biology.

[22]  J. M. Mullin,et al.  Increased Tight Junction Permeability Can Result from Protein Kinase C Activation/Translocation and Act as a Tumor Promotional Event in Epithelial Cancers , 2000, Annals of the New York Academy of Sciences.

[23]  J. Shabanowitz,et al.  A myosin I isoform in the nucleus. , 2000, Science.

[24]  E. Sharlow,et al.  The protease-activated receptor-2 upregulates keratinocyte phagocytosis. , 2000, Journal of cell science.

[25]  A. Shevchenko,et al.  Direct Involvement of Yeast Type I Myosins in Cdc42-Dependent Actin Polymerization , 2000, The Journal of cell biology.

[26]  L. Machesky.  The Tails of Two Myosins , 2000, The Journal of cell biology.

[27]  M. Itoh,et al.  Direct Binding of Three Tight Junction-Associated Maguks, Zo-1, Zo-2, and Zo-3, with the Cooh Termini of Claudins , 1999, The Journal of cell biology.

[28]  P. Cappuccinelli,et al.  Expression of Vibrio cholerae zonula occludens toxin and analysis of its subcellular localization. , 1999, Microbial pathogenesis.

[29]  James M. Anderson,et al.  Connexin-Occludin Chimeras Containing the Zo-Binding Domain of Occludin Localize at Mdck Tight Junctions and Nrk Cell Contacts , 1999, Journal of Cell Biology.

[30]  M. Hollenberg,et al.  Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands. , 1999, The Journal of pharmacology and experimental therapeutics.

[31]  J. Anderson,et al.  Transmembrane proteins in the tight junction barrier. , 1999, Journal of the American Society of Nephrology : JASN.

[32]  James M. Anderson,et al.  The Tight Junction Protein ZO-1 Establishes a Link between the Transmembrane Protein Occludin and the Actin Cytoskeleton* , 1998, The Journal of Biological Chemistry.

[33]  S. Goldblum,et al.  The counteradhesive protein SPARC regulates an endothelial paracellular pathway through protein tyrosine phosphorylation. , 1998, Biochemical and biophysical research communications.

[34]  J. Anderson,et al.  Tight junction assembly during mouse blastocyst formation is regulated by late expression of ZO-1 alpha+ isoform. , 1997, Development.

[35]  C. V. Van Itallie,et al.  Occludin confers adhesiveness when expressed in fibroblasts. , 1997, Journal of cell science.

[36]  M. Wagner,et al.  ATP depletion alters myosin I beta cellular location in LLC-PK1 cells. , 1997, The American journal of physiology.

[37]  L. Cantley,et al.  Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains , 1997, Science.

[38]  James M. Anderson,et al.  The SH3 domain of the tight junction protein ZO‐1 binds to a serine protein kinase that phosphorylates a region C‐terminal to this domain , 1996, FEBS letters.

[39]  C. Fiorentini,et al.  Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. , 1995, The Journal of clinical investigation.

[40]  C. V. Van Itallie,et al.  Zonula occludens (ZO)-1 and ZO-2: membrane-associated guanylate kinase homologues (MAGuKs) of the tight junction. , 1995, Biochemical Society transactions.

[41]  J. Kaper,et al.  Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. V. Van Itallie,et al.  ZO-1 mRNA and protein expression during tight junction assembly in Caco- 2 cells , 1989, The Journal of cell biology.

[43]  A. Fanning.  ZO Proteins and Tight Junction Assembly , 2006 .

[44]  A. Stammati,et al.  The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics , 2005, Cell Biology and Toxicology.

[45]  M. Rędowicz.  Regulation of nonmuscle myosins by heavy chain phosphorylation , 2004, Journal of Muscle Research & Cell Motility.

[46]  M. Balda,et al.  Intracellular signaling in classical and new tight junction functions , 2001 .

[47]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[48]  A. Fasano,et al.  Zonula occludens toxin structurefunction analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain , 2000 .